Research Masterclass in Radiotherapy Physics 2017

Chen W, Unkelbach J, Trofimov A, Madden T, Kooy H, Bortfeld T, Craft D. Including  robustness in multi‐criteria optimization for intensity‐modulated proton therapy. Phys Med  Biol. 2012 Feb 7;57(3):591‐608. 

Fredriksson A, Forsgren A, Hårdemark B. Minimax optimization for handling range and setup  uncertainties in proton therapy. Med Phys. 2011 Mar;38(3):1672‐84.  

Fredriksson A. A characterization of robust radiation therapy treatment planning methods‐ from expected value to worst case optimization. Med Phys. 2012 Aug;39(8):5169‐81.  

Fredriksson A, Forsgren A, Hårdemark B. Maximizing the probability of satisfying the clinical  goals in radiation therapy treatment planning under setup uncertainty. Med Phys. 2015  Jul;42(7):3992.  

Fredriksson A, Bokrantz R. A critical evaluation of worst case optimization methods for  robust intensity‐modulated proton therapy planning. Med Phys. 2014 Aug;41(8) 

Fredriksson A, Bokrantz R. The scenario‐based generalization of radiation therapy margins.  Phys Med Biol. 2016 Mar 7;61(5):2067‐82.  Bokrantz R, Fredriksson A. Scenario‐based radiation therapy margins for patient setup,  organ motion, and particle range uncertainty. Phys Med Biol. 2017 Feb 21;62(4):1342‐1357  Witte MG, van der Geer J, Schneider C, Lebesque JV, Alber M, van Herk M. IMRT   optimization including random and systematic geometric errors based on the expectation of  TCP and NTCP. Med Phys. 2007 Sep;34(9):3544‐55. 

Bohoslavsky R, Witte MG, Janssen TM, van Herk M. Probabilistic objective functions for  margin‐less IMRT planning. Phys Med Biol. 2013 Jun 7;58(11):3563‐80.  

Fontanarosa D, van der Laan HP, Witte M, Shakirin G, Roelofs E, Langendijk JA, Lambin P,  van Herk M. An in silico comparison between margin‐based and probabilistic target‐ planning approaches in head and neck cancer patients. Radiother Oncol. 2013  Dec;109(3):430‐6.   Witte M, Shakirin G, Houweling A, Peulen H, van Herk M. Dealing with geometric  uncertainties in dose painting by numbers: introducing the ΔVH. Radiother Oncol. 2011  Sep;100(3):402‐6.   Fontanarosa D, Witte M, Meijer G, Shakirin G, Steenhuijsen J, Schuring D, van Herk M,  Lambin P. Probabilistic evaluation of target dose deterioration in dose painting by numbers  for stage II/III lung cancer. Pract Radiat Oncol. 2015 Jul‐Aug;5(4):e375‐82.